Ginkgo Bioworks Holdings, Inc. — insider transactions

14 transactions on record · DNA · CIK 1830214

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
14
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
2
Bought, 3m
$0
Sold, 3m
$8.2K
Median disclosure lag
4.0 d
trade date to filing date
Largest single trade, 24m
$5.9K
2026-07-17
Director share, 12m
0.0%
of transactions where role is stated
Current run
14 sells
consecutive same-direction transactions
Net 3m flow
-$8.2K
purchases minus sales
Total on record
14

Transactions

14 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-08-252026-08-214Coen Steven P.See remarksExercise of derivative156——filing
2026-08-252026-08-214Coen Steven P.See remarksExercise of derivative156——filing
2026-08-252026-08-241Coen Steven P.See remarksOpen market sale330$6.98$2.3Kfiling
2026-08-252026-08-214Coen Steven P.See remarksExercise of derivative587——filing
2026-08-252026-08-214Coen Steven P.See remarksExercise of derivative587——filing
2026-07-302026-07-282Canton Barry10% OwnerGrant or award39,038——filing
2026-07-302026-07-282Canton Barry10% OwnerGrant or award117,135——filing
2026-07-302026-07-282Canton Barry10% OwnerGrant or award35,736——filing
2026-07-302026-07-282Canton Barry10% OwnerGrant or award127,423——filing
2026-07-202026-07-173Coen Steven P.See remarksOpen market sale752$7.90$5.9Kfiling
2026-07-202026-07-164Coen Steven P.See remarksExercise of derivative312——filing
2026-07-202026-07-164Coen Steven P.See remarksExercise of derivative312——filing
2026-07-202026-07-164Coen Steven P.See remarksExercise of derivative1,174——filing
2026-07-202026-07-164Coen Steven P.See remarksExercise of derivative1,174——filing

Source: U.S. Securities and Exchange Commission, EDGAR

Ginkgo Bioworks Holdings, Inc. insider transactions — 14 filings on record — investment.com